Skip to main content

Art is
Blood Cancer United

man seated in yellow shirt

I was living in San Jose and had gone walking with a friend in a local park that followed the stream. It was December 15, 2006. Tom noticed that I had difficulty climbing up the five-foot stream embankment that the path went through. I myself didn’t recall this. Ten days later while visiting my wife’s children in Fairfax, the children and I went on a trail as we always did on Christmas morning. I found myself badly winded and returned to their home while they continued the hike. Then I noticed that I was not attracted to the Christmas feast. In early January, I had a scheduled annual physical. My primary care called me the following day and said, “Your blood tests are normal, but are unusual. I want a second test in two weeks”. This time I was anemic, and I visited a hematologist. She described 13 ways I could become anemic, the least likely being leukemia, and scheduled me for a bone marrow biopsy. The following week I flew cross country to an interview to be selected as a Trustee of a national nonprofit. I didn’t get elected – a nurse at the meeting told me later she noticed how sick I looked.

On February 5th while showering, I felt a sharp pain in my arm and became dizzy. I quickly dressed and asked my wife to take me to the emergency room. It was there that I received three pints of blood and was admitted to the hospital. The scheduled biopsy was done the next day and I began treatment for AML. The biopsy revealed an inversion of chromosome 16. 35 days later a second biopsy showed no evidence of AML. I received 6 cycles of consolidation. I remain in remission and the hematologist now uses the word cure.

In January four years later, I had a CT-scan, looking for kidney stones. They also found an enlarged lymph node, eventually diagnosed as Stage 2 follicular lymphoma. I had five cancerous nodes all below the diaphragm. I was treated with RSVP, taking Rituxan for 14 months. They too are gone and have not returned.

I was 69 when AML treatment began. When I was diagnosed the protocol was to not treat patients once they reached the age of 70. I turned 70 during consolidation, so I was told I couldn’t continue treatment. A second opinion suggested that being otherwise healthy, I could be treated. My hematologist didn’t follow the original protocol. She continued chemo at lower doses but for more cycles. As you might have noticed, I survived. Treatment was optional for the lymphoma. Very often “Watch and Wait” is the approach recommended. My hematologist included me in most decisions and suggested treatment since I appeared to tolerate chemo well. Maybe I couldn’t be treated later because of age. There were no clinical trials available to me and also not needed in my case. I’m not averse to participating in clinical trials. Earlier I had participation in the Proscar prostate cancer trial as well as the shingles trial.

I learned about LLS during AML treatment from the hospital social worker. Their pamphlets were a good way for me to learn enough to ask more intelligent questions. Their financial help was an unexpected gift. Their annual Cancer Seminar allowed me to ask questions to and obtain insights from the researchers who knew everything about the advantages and disadvantages of specific treatments. Their First Connection Program was helpful. I was able to talk to people who survived. Now I’m able to share with new patients the possibility of long-term recovery.

Art

AML Survivor

We are Blood Cancer United.

Everyone affected by blood cancer—patients, survivors, caregivers, researchers, advocates, fundraisers, everyone—has a story. Share yours.
Copilot said: Close-up of two older adults seated together indoors, smiling and leaning side by side at a table, highlighting support, connection, and shared experiences within the blood cancer community and survivorship awareness.

Lawrence

acute myeloid leukemia (AML)

Snapshot of Tracy wearing a hat and glasses in front of a waterfall, a cancer survivor

Tracy

Acute myeloid leukemia (AML)

Gabriele Papa, AML

Gabriele

acute myeloid leukemia (AML)

Gerardo (Jerry), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) patient

Gerardo (Jerry)

myelofibrosis (MF), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) - In memory

Two individuals stand outdoors on a grassy area near trees and a building, posing side by side. One individual wears a white textured dress and carries a green shoulder bag, while the other wears a light-colored outfit with a white coat and holds a bouquet of pink flowers tied with a ribbon. Natural greenery and a walkway are visible in the background, suggesting a celebratory or milestone moment.

Liz

acute myeloid leukemia (AML)

Individual wearing a navy quarter-zip with a visible ID badge stands beside a bookshelf in a bright indoor school library or community space, with glass doors and a red “EXIT” sign in the background, conveying a calm, supportive environment for learning and connection related to blood cancer awareness and community care.

Michael

acute myeloid leukemia (AML)

Here is descriptive, SEO‑driven alt text that includes **blood cancer**, stays objective, and avoids assumptions:  **Alt text:**   Two people posing for a close-up outdoor selfie at night near a brightly lit holiday tree in an urban plaza, with illuminated buildings in the background; image commonly shared in personal storytelling connected to blood cancer awareness, caregiver support, and survivorship advocacy.

Lia

Family member and caregiver

Headshot of Bill, a cancer survivor

Bill

acute myeloid leukemia (AML)

Black and white portrait of Heather, AML survivor

Heather

acute myeloid leukemia (AML)

Acute myeloid leukemia survivor wearing a blue buttoned shirt in front of a beautiful landscape

Zac

acute myeloid leukemia (AML)

carley-c_dam_file_18021.jpg

Carley

In Memory

child in a hospital room

Zach

In Memory

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.